Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K
09:17am, Saturday, 28'th Mar 2026
2,625 shares were exercised and sold on March 11, 2026, generating a transaction value of approximately $285,000 at a weighted average sale price of around $108.50 per share. This disposition represen
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know
08:06pm, Friday, 27'th Mar 2026
An executive of LeMaitre Vascular reported selling 2,625 shares of the company for $285,000 on March 11, 2026. The sale represented 28.22% of Kamke's direct common stock holdings, reducing the positio
LeMaitre Vascular, Inc. $LMAT Shares Acquired by Congress Asset Management Co.
01:39pm, Tuesday, 24'th Mar 2026
Congress Asset Management Co. boosted its stake in LeMaitre Vascular, Inc. (NASDAQ: LMAT) by 5.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 732,33
The Two Forces Reshaping Your Portfolio - February Dividend Income Report
11:45pm, Friday, 20'th Mar 2026
The market has been going through a visible rotation. Dividend payers have been outperforming so far this year as investors rotate from large-cap AI names into “old economy” stocks. If you own sof
Dynamic Technology Lab Private Ltd Invests $477,000 in LeMaitre Vascular, Inc. $LMAT
03:54am, Thursday, 12'th Mar 2026
Dynamic Technology Lab Private Ltd bought a new stake in shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) in the undefined quarter, according to the company in its most recent 13F filing with the SEC.
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $105.80 Average Target Price from Analysts
04:03am, Saturday, 07'th Mar 2026
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT - Get Free Report) have been assigned an average rating of "Hold" from the seven brokerages that are currently covering the firm, Marketbeat Ratings rep
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross
10:56am, Monday, 02'nd Mar 2026
After reaching an important support level, LeMaitre Vascular, Inc. (LMAT) could be a good stock pick from a technical perspective. LMAT recently experienced a "golden cross" event, which saw its 50-da
LeMaitre Vascular: The Compounder Keeps Compounding
03:01pm, Friday, 27'th Feb 2026
LeMaitre Vascular delivered strong Q4 and FY 2025 results, with 16% YoY sales growth and broad-based margin expansion. Artegraft's international rollout exceeded expectations, with 2025 sales doubling
LeMaitre to Participate at Upcoming Investor Conferences in March
02:50pm, Friday, 27'th Feb 2026
BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March.
LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript
01:47am, Thursday, 26'th Feb 2026
LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript
LeMaitre Q4 2025 Financial Results
04:05pm, Wednesday, 25'th Feb 2026
BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarter
LeMaitre Vascular, Inc. $LMAT Shares Purchased by Public Sector Pension Investment Board
04:04am, Wednesday, 18'th Feb 2026
Public Sector Pension Investment Board raised its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) by 15.8% in the undefined quarter, according to its most recent 13F filing with the Secur
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
09:47am, Wednesday, 11'th Feb 2026
BURLINGTON, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2025 financial results on Wednesday, February 25, 202
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of “Moderate Buy” by Brokerages
04:46am, Saturday, 07'th Feb 2026
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the firm, MarketBeat Ratings r
Campbell & CO Investment Adviser LLC Takes $851,000 Position in LeMaitre Vascular, Inc. $LMAT
04:31am, Tuesday, 20'th Jan 2026
Campbell and CO Investment Adviser LLC acquired a new stake in shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) in the third quarter, according to its most recent filing with the Securities and Exchan
